ProShare Advisors LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$292,604
-57.4%
7,692
+2.1%
0.00%
-50.0%
Q2 2023$686,439
-45.2%
7,535
-60.3%
0.00%
-50.0%
Q1 2023$1,251,525
+6.9%
18,974
-16.2%
0.00%0.0%
Q4 2022$1,170,559
-18.7%
22,637
+7.4%
0.00%
-33.3%
Q3 2022$1,439,000
+72.1%
21,068
+13.8%
0.01%
+100.0%
Q2 2022$836,000
-30.7%
18,510
-22.0%
0.00%0.0%
Q1 2022$1,207,000
-12.3%
23,745
-18.5%
0.00%0.0%
Q4 2021$1,377,000
+55.4%
29,151
+8.4%
0.00%
+50.0%
Q3 2021$886,000
-55.2%
26,894
-14.1%
0.00%
-66.7%
Q2 2021$1,979,000
+69.7%
31,313
+15.2%
0.01%
+50.0%
Q1 2021$1,166,000
-18.5%
27,179
+8.7%
0.00%
-20.0%
Q4 2020$1,430,000
+142.4%
24,993
+27.9%
0.01%
+66.7%
Q3 2020$590,000
-10.7%
19,547
-3.4%
0.00%
-25.0%
Q2 2020$661,000
+80.6%
20,227
+48.1%
0.00%
+33.3%
Q1 2020$366,000
-41.5%
13,656
-33.2%
0.00%0.0%
Q4 2019$626,000
+14.2%
20,436
-10.2%
0.00%0.0%
Q3 2019$548,000
-3.0%
22,749
+2.1%
0.00%0.0%
Q2 2019$565,000
+26.1%
22,278
-3.1%
0.00%0.0%
Q1 2019$448,000
+48.3%
22,995
+0.6%
0.00%
+50.0%
Q4 2018$302,00022,8680.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders